Prediction of intensive care admission and hospital mortality in COVID-19 patients using demographics and baseline laboratory data

dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorAVELINO-SILVA, Vivian I.
dc.contributor.authorAVELINO-SILVA, Thiago J.
dc.contributor.authorALIBERTI, Marlon J. R.
dc.contributor.authorFERREIRA, Juliana C.
dc.contributor.authorCOBELLO JUNIOR, Vilson
dc.contributor.authorSILVA, Katia R.
dc.contributor.authorPOMPEU, Jose E.
dc.contributor.authorANTONANGELO, Leila
dc.contributor.authorMAGRI, Marcello M.
dc.contributor.authorBARROS FILHO, Tarcisio E. P.
dc.contributor.authorSOUZA, Heraldo P.
dc.contributor.authorKALLAS, Esper G.
dc.contributor.groupauthorHCFMUSP COVID-19 Study Grp
dc.date.accessioned2023-06-21T14:08:00Z
dc.date.available2023-06-21T14:08:00Z
dc.date.issued2023
dc.description.abstractIntroduction: Optimized allocation of medical resources to patients with COVID-19 has been a critical concern since the onset of the pandemic.Methods: In this retrospective cohort study, the authors used data from a Brazilian tertiary university hospital to explore predictors of Intensive Care Unit (ICU) admission and hospital mortality in patients admitted for COVID19. Our primary aim was to create and validate prediction scores for use in hospitals and emergency departments to aid clinical decisions and resource allocation. Results: The study cohort included 3,022 participants, of whom 2,485 were admitted to the ICU; 1968 survived, and 1054 died in the hospital. From the complete cohort, 1,496 patients were randomly assigned to the derivation sample and 1,526 to the validation sample. The final scores included age, comorbidities, and baseline laboratory data. The areas under the receiver operating characteristic curves were very similar for the derivation and validation samples. Scores for ICU admission had a 75% accuracy in the validation sample, whereas scores for death had a 77% accuracy in the validation sample. The authors found that including baseline flu-like symptoms in the scores added no significant benefit to their accuracy. Furthermore, our scores were more accurate than the previously published NEWS-2 and 4C Mortality Scores.Discussion and conclusions: The authors developed and validated prognostic scores that use readily available clinical and laboratory information to predict ICU admission and mortality in COVID-19. These scores can become valuable tools to support clinical decisions and improve the allocation of limited health resources.eng
dc.description.indexMEDLINE
dc.description.indexPubMed
dc.description.indexWoS
dc.description.indexScopus
dc.description.indexScielo
dc.description.sponsorshipHCFMUSP
dc.identifier.citationCLINICS, v.78, article ID 100183, 8p, 2023
dc.identifier.doi10.1016/j.clinsp.2023.100183
dc.identifier.eissn1980-5322
dc.identifier.issn1807-5932
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/53890
dc.language.isoeng
dc.publisherELSEVIER ESPANAeng
dc.relation.ispartofClinics
dc.rightsopenAccesseng
dc.rights.holderCopyright ELSEVIER ESPANAeng
dc.subjectCOVID-19eng
dc.subjectSARS-CoV-2eng
dc.subjectCritical Careeng
dc.subjectMortalityeng
dc.subjectIntensive Careeng
dc.subjectRisk Scoreeng
dc.subjectPredictioneng
dc.subject.wosMedicine, General & Internaleng
dc.titlePrediction of intensive care admission and hospital mortality in COVID-19 patients using demographics and baseline laboratory dataeng
dc.typearticleeng
dc.type.categoryoriginal articleeng
dc.type.versionpublishedVersioneng
dspace.entity.typePublication
hcfmusp.citation.scopus2
hcfmusp.contributor.author-fmusphcVIVIAN HELENA IIDA AVELINO DA SILVA
hcfmusp.contributor.author-fmusphcTHIAGO JUNQUEIRA AVELINO DA SILVA
hcfmusp.contributor.author-fmusphcMARLON JULIANO ROMERO ALIBERTI
hcfmusp.contributor.author-fmusphcJULIANA CARVALHO FERREIRA
hcfmusp.contributor.author-fmusphcVILSON COBELLO JUNIOR
hcfmusp.contributor.author-fmusphcKATIA REGINA DA SILVA
hcfmusp.contributor.author-fmusphcJOSE EDUARDO POMPEU
hcfmusp.contributor.author-fmusphcLEILA ANTONANGELO
hcfmusp.contributor.author-fmusphcMARCELLO MIHAILENKO CHAVES MAGRI
hcfmusp.contributor.author-fmusphcTARCISIO ELOY PESSOA DE BARROS FILHO
hcfmusp.contributor.author-fmusphcHERALDO POSSOLO DE SOUZA
hcfmusp.contributor.author-fmusphcESPER GEORGES KALLAS
hcfmusp.description.articlenumber100183
hcfmusp.description.volume78
hcfmusp.origemWOS
hcfmusp.origem.pubmed36989546
hcfmusp.origem.scieloSCIELO:S1807-59322023000100228
hcfmusp.origem.scopus2-s2.0-85151424417
hcfmusp.origem.wosWOS:000965428800001
hcfmusp.publisher.cityMADRIDeng
hcfmusp.publisher.countrySPAINeng
hcfmusp.relation.referenceAlencar J, 2022, FRONT MED-LAUSANNE, V9, DOI 10.3389/fmed.2022.779516eng
hcfmusp.relation.referenceAlhalaseh YN, 2021, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.616277eng
hcfmusp.relation.referenceBolourani S, 2021, J MED INTERNET RES, V23, DOI 10.2196/24246eng
hcfmusp.relation.referenceBradley P, 2020, BMJ OPEN RESPIR RES, V7, DOI 10.1136/bmjresp-2020-000729eng
hcfmusp.relation.referenceClift AK, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m3731eng
hcfmusp.relation.referencecovid19.who, WHO CORONAVIRUS COVIeng
hcfmusp.relation.referenceDaniels JP, 2021, EVERYTHING IS COLLAPeng
hcfmusp.relation.referenceDas AK, 2020, PEERJ, V8, DOI 10.7717/peerj.10083eng
hcfmusp.relation.referenceEmanuel EJ, 2020, NEW ENGL J MED, V382, P2049, DOI 10.1056/NEJMsb2005114eng
hcfmusp.relation.referenceFerreira JC, 2021, ANN INTENSIVE CARE, V11, DOI 10.1186/s13613-021-00882-weng
hcfmusp.relation.referenceGoodacre S, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0245840eng
hcfmusp.relation.referenceHarris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010eng
hcfmusp.relation.referenceIslam N, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj-2021-066768eng
hcfmusp.relation.referenceKnight SR, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3339eng
hcfmusp.relation.referenceKuhn A., 2020, S KOREAN CITY IS CHAeng
hcfmusp.relation.referenceKurtz P, 2021, INTENS CARE MED, V47, P538, DOI 10.1007/s00134-021-06388-0eng
hcfmusp.relation.referenceLiao XL, 2020, INTENS CARE MED, V46, P357, DOI 10.1007/s00134-020-05954-2eng
hcfmusp.relation.referenceLiu H, 2021, MED N Y, V2, P4eng
hcfmusp.relation.referenceLivingston E, 2020, JAMA-J AM MED ASSOC, V323, P1912, DOI 10.1001/jama.2020.5317eng
hcfmusp.relation.referenceLopez-Escobar A, 2021, DIAGNOSTICS, V11, DOI 10.3390/diagnostics11040596eng
hcfmusp.relation.referenceMcMahon DE, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008412eng
hcfmusp.relation.referenceMiller JL, 2022, ACAD EMERG MED, V29, P206, DOI 10.1111/acem.14447eng
hcfmusp.relation.referenceMounk Y., 2020, ATLANTICeng
hcfmusp.relation.referenceNeto FL, 2021, CLIN MICROBIOL INFEC, V27, DOI 10.1016/j.cmi.2021.03.002eng
hcfmusp.relation.referenceourworldindata.org, CORONAVIRUS COVID 19eng
hcfmusp.relation.referencePhillips T, 2021, COMPLETE MASSACRE HOeng
hcfmusp.relation.referenceRanney ML, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMp2006141eng
hcfmusp.relation.referenceRanzani OT, 2021, LANCET RESP MED, V9, P407, DOI 10.1016/S2213-2600(20)30560-9eng
hcfmusp.relation.referenceSchumaker E, 2021, COMPLETE COLLAPSE PReng
hcfmusp.relation.referenceWollenstein-Betech Salomon, 2020, Int J Med Inform, V142, P104258, DOI [10.1016/j.ijmedinf.2020.104258, 10.1101/2020.05.03.20089813]eng
hcfmusp.relation.referencewww.cdc, VARIANTS GENOMIC SUReng
hcfmusp.scopus.lastupdate2024-05-17
relation.isAuthorOfPublication86c321c7-5cde-4865-b233-ae342a5e5dee
relation.isAuthorOfPublication3fdc83c2-f8fe-449b-90c7-d3efbb96c275
relation.isAuthorOfPublicatione2979c87-902f-4301-87f7-51d15463e027
relation.isAuthorOfPublicationd9ff0200-05aa-44bb-b4ec-35039188d680
relation.isAuthorOfPublication97dfab63-b4cb-48ea-b65c-ccd9fac2928f
relation.isAuthorOfPublicationfb5f5d28-4fa3-47c3-aeea-214dcbce9cf2
relation.isAuthorOfPublicatione6a7d63e-916b-4ed8-b573-a204e6a12fdd
relation.isAuthorOfPublication02769cb7-5644-4d8b-b9bc-60221e051b83
relation.isAuthorOfPublicationd659102b-c47c-42a8-a6cb-9f0de5c3fbba
relation.isAuthorOfPublication92868e70-2c3f-49b7-86ec-fe73d0eb887a
relation.isAuthorOfPublication9a561822-4752-4c79-87c4-0b9ca5a67a36
relation.isAuthorOfPublication28071dc0-9dc3-4896-81cf-c90be6515b24
relation.isAuthorOfPublication.latestForDiscovery86c321c7-5cde-4865-b233-ae342a5e5dee
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Carregando...
Imagem de Miniatura
Nome:
art_AVELINO-SILVA_Prediction_of_intensive_care_admission_and_hospital_mortality_2023.PDF
Tamanho:
954.01 KB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)